A record of what Marketsmith India Analysis said publicly, with the source. Not advice.
“Recommends buying Biocon in the ₹375–390 range, targeting ₹458 with a stop loss at ₹350, over a 2–3 month timeframe. The call is based on technical analysis and market direction methodology.”
Marketsmith India Analysis’s track record (trackable calls only): 322 graded calls · 95% CI 22–32%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.
Entry zone: ₹375–₹390. The call starts at the first close that comes into it.
Target ₹458, stop ₹350, as stated.
Window: 90 days, the time frame the call states ("2–3 month").
The stop ₹350 was reached on a close before the target ₹458. Miss.
The grader’s working: R3 TRADE_SETUP: entered ₹388.05 on 2025-01-22 (stated entry ₹375–390 zone, ZONE entry, filled); stop ₹350 breached at close ₹349.35 on 2025-02-14. Window 90 days — rule H1: the quote states "2–3 month".